CompoAtlas

EAA

EAA, licence 80109791: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
PWR Nutrition
NPN or DIN-HM
80109791
Status
Active licence
Licence date
10 May 2021
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Acide 2-aminoéthanesulfonique

Source : Taurine

200.0 mgNot calculated
L-phénylalanine

Source : Zea mays - Graine

140.0 mgNot calculated
L-phénylalanine

Source : L-phénylalanine

140.0 mgNot calculated
L-Citrulline

Source : Malate de citrulline

1500.0 mgNot calculated
L-Leucine

Source : L-Leucine

1824.0 mgNot calculated
L-Leucine

Source : Glycine max - Graine

1824.0 mgNot calculated
L-Leucine

Source : Anas falcata - plume

1824.0 mgNot calculated
L-Leucine

Source : Zea mays - Graine

1824.0 mgNot calculated
L-Isoleucine

Source : Zea mays - Graine

100.0 mgNot calculated
L-Isoleucine

Source : Glycine max - Graine

100.0 mgNot calculated
L-Isoleucine

Source : L-isoleucine

100.0 mgNot calculated
L-valine

Source : Zea mays - Graine

1000.0 mgNot calculated
L-valine

Source : L-valine

1000.0 mgNot calculated
L-valine

Source : Glycine max - Graine

1000.0 mgNot calculated
L-Méthionine

Source : Glycine max - Graine

90.0 mgNot calculated
L-Méthionine

Source : L-méthionine

90.0 mgNot calculated
L-Thréonine

Source : Zea mays - Graine

40.0 mgNot calculated
L-Thréonine

Source : L-thréonine

40.0 mgNot calculated
L-Lysine

Source : Glycine max - Graine

100.0 mgNot calculated
L-Lysine

Source : Zea mays - Graine

100.0 mgNot calculated
L-Lysine

Source : L-Lysine

100.0 mgNot calculated
Potassium

Source : Citrate de potassium

100.0 mgNot calculated

Non-medicinal ingredients

Saveur, Sucralose, Dioxyde de silicium, Poudre de fruit de Noix de coco, Rouge FD&C N° 40, Acide citrique, Acésulfame-K, Bleu FD&C n° 1, Jaune FD&C No. 5

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18.0 Année(s)1.0 Mesures1.0 Jour

Uses authorised in Canada

Aide à développer la masse musculaire/le tissu musculaire maigre lorsqu'utilisé en association avec un entraînement régulier [en poids/en résistance] et une diète équilibrée. Source d'un acide/d'acides aminé(s) (essentiel(s)) jouant un rôle dans la synthèse des protéines musculaires. Source d'un acide/d'acides aminé(s) (non-essentiel(s)) jouant un rôle dans la synthèse des protéines musculaires. Source d'un acide/d'acides aminé(s) essentiel(s) pour le maintien d'une bonne santé. Supplément à l'entraînement. Supplément athlétique.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80109791

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line